Dyne Therapeutcs Rg

Dyne Therapeutics is a clinical‑stage biotech building a pipeline of FORCE platform‑based therapeutics for neuromuscular disorders—including myotonic dystrophy, Duchenne, facioscapulohumeral dystrophy and Pompe—targeting US rare disease markets.

Headquarters: United States (USA)

Dyne Therapeutcs Rg Logo
Company Profile
  • Employees: 240
  • HQ: Waltham
Traded Instruments
+ Add Instrument 1
Symbol Name Type Exchange Currency ISIN Status Actions
DYN Dyne Therapeutcs Rg
Cap: 3.0B
EQUITY NMS USD US26818M1080 Active
📈
Home Login